A573was inadequate response from traditional disease-modifying anti-rheumatic drugs (DMARDs) alone (54.9%), followed by symptom control (13.4%). Among the remaining responses, clinical data (e.g., results from clinical trials) was cited most frequently in the UK (17.1%) compared to Germany/Spain (9.0%/4.7%), while personal experience was cited most in Germany (15.3%) vs. UK/Spain (2.7%/0.9%). Inadequate response to DMARDs was most frequently reported for adalimumab (61.5%) vs. etanercept (46.9%) or other biologics (40.2%); inadequate DMARD symptom control was more cited for etanercept (18.8%) vs. adalimumab (11.1%) or other biologics (9.8%). Among the 23 patients who switched to a second biologic agent, 72.7% were switched due to inadequate response to the first biologic agent. ConClusions: Across the three study countries, prescribers most frequently initiated biologic therapy due to inadequate response or lack of symptom control on traditional DMARDs. Other reasons varied by country, however differences across biologic agents prescribed were minimal.
cal response to short and long term treatment, based on all available randomized controlled trials (and indirect comparisons, where appropriate). All costs, in 2012 Colombian pesos (1 USD$ = COP$1800) were obtained locally, using official databases for drug costs, and tariff manual (ISS 2001+30%) for procedures and complications. HAQ scores were used to calculate utilities, measured in QALYs. Annual discount rate was 3% both for cost outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.